Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-07-06 Purchase |
2023-07-07 08:03 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
320 | $14.88 | $4,762 | 3,231,099 (Direct) |
View |
| 2023-07-05 Purchase |
2023-07-06 07:45 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
1,176 | $15.52 | $18,252 | 2,529,201 (Direct) |
View |
| 2023-06-26 Purchase |
2023-06-27 08:45 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
16,760 | $16.46 | $275,870 | 2,528,025 (Direct) |
View |
| 2023-06-26 Purchase |
2023-06-27 08:45 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
750 | $16.5 | $12,375 | 3,230,779 (Direct) |
View |
| 2023-06-23 Purchase |
2023-06-26 08:45 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
73,175 | $17.43 | $1,275,440 | 2,511,265 (Direct) |
View |
| 2023-06-21 Purchase |
2023-06-23 08:59 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
13,090 | $17.72 | $231,964 | 2,438,090 (Direct) |
View |
| 2023-06-21 Purchase |
2023-06-22 08:42 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
500 | $17.88 | $8,940 | 3,230,029 (Direct) |
View |
| 2023-06-16 Purchase |
2023-06-20 08:25 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
12,700 | $17.75 | $225,425 | 2,425,000 (Direct) |
View |
| 2023-06-15 Purchase |
2023-06-16 06:46 am |
Nuvectis Pharma Inc. | NVCT | Mosseri Marlio Charles 10% Owner |
32,124 | $17.71 | $568,848 | 2,412,300 (Direct) |
View |
| 2023-06-07 Purchase |
2023-06-08 9:28 pm |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
350 | $17.45 | $6,108 | 3,229,529 (Direct) |
View |
| 2023-05-31 Purchase |
2023-06-01 08:00 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
330 | $17.28 | $5,702 | 3,229,179 (Direct) |
View |
| 2023-05-24 Purchase |
2023-05-26 09:29 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
200 | $17.49 | $3,498 | 3,228,849 (Direct) |
View |
| 2023-05-16 Purchase |
2023-05-18 07:00 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
320 | $17.02 | $5,448 | 3,228,649 (Direct) |
View |
| 2023-03-27 Purchase |
2023-03-28 08:30 am |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off |
500 | $11.55 | $5,775 | 1,373,819 (Direct) |
View |
| 2023-03-23 Purchase |
2023-03-27 08:21 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
230 | $12.13 | $2,790 | 3,228,329 (Direct) |
View |
| 2023-03-21 Purchase |
2023-03-23 08:30 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
480 | $12.08 | $5,798 | 3,228,099 (Direct) |
View |
| 2023-03-21 Purchase |
2023-03-22 08:30 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
420 | $11.99 | $5,036 | 1,361,955 (Direct) |
View |
| 2023-03-15 Purchase |
2023-03-17 08:31 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
670 | $10.71 | $7,176 | 1,361,535 (Direct) |
View |
| 2023-03-14 Purchase |
2023-03-16 4:45 pm |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
2,160 | $10.86 | $23,465 | 3,227,619 (Direct) |
View |
| 2022-12-21 Purchase |
2022-12-22 08:30 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
500 | $7.65 | $3,825 | 1,245,865 (Direct) |
View |
| 2022-11-30 Purchase |
2022-11-30 5:43 pm |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
150 | $7.45 | $1,118 | 3,015,459 (Direct) |
View |
| 2022-11-25 Purchase |
2022-11-29 4:31 pm |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
450 | $7.41 | $3,335 | 3,015,309 (Direct) |
View |
| 2022-11-17 Purchase |
2022-11-21 08:39 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
750 | $7.2333 | $5,425 | 3,014,859 (Direct) |
View |
| 2022-11-16 Purchase |
2022-11-18 08:30 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
300 | $7.15 | $2,145 | 1,245,365 (Direct) |
View |
| 2022-11-10 Purchase |
2022-11-16 08:30 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
1,000 | $7.07 | $7,070 | 3,014,109 (Direct) |
View |
| 2022-09-28 Purchase |
2022-10-03 08:16 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
1,000 | $7.345 | $7,345 | 3,013,109 (Direct) |
View |
| 2022-09-23 Purchase |
2022-09-27 08:45 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
220 | $7.87 | $1,731 | 1,245,065 (Direct) |
View |
| 2022-09-23 Purchase |
2022-09-27 08:44 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
1,500 | $7.85 | $11,775 | 3,012,109 (Direct) |
View |
| 2022-09-01 Purchase |
2022-09-06 08:00 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
1,700 | $8.2935 | $14,099 | 3,010,609 (Direct) |
View |
| 2022-09-02 Purchase |
2022-09-06 08:00 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
404 | $8.31 | $3,357 | 1,244,845 (Direct) |
View |
| 2022-08-31 Purchase |
2022-09-02 08:30 am |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
3,006 | $8.07 | $24,258 | 1,244,441 (Direct) |
View |
| 2022-08-23 Purchase |
2022-08-30 07:35 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
1,500 | $9.0467 | $13,570 | 3,008,909 (Direct) |
View |
| 2022-08-18 Purchase |
2022-08-22 09:00 am |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
19,426 | $8.6855 | $168,725 | 3,007,409 (Direct) |
View |
| 2022-08-11 Purchase |
2022-08-16 4:05 pm |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
19,669 | $8.4 | $165,220 | 2,987,983 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-16 Option Award |
2023-06-20 08:16 am |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Oliviero James F III Director |
18,000 | $0 | 27,828 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-20 08:16 am |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Kaplan Matthew L. Director |
18,000 | $0 | 53,760 (Direct) |
View |
| 2023-06-16 Option Award |
2023-06-20 08:15 am |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Hoberman Kenneth Director |
18,000 | $0 | 73,140 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-13 5:05 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Poradosu Enrique Chief Science & Business Off |
115,000 | $0 | 1,373,319 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-13 5:04 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | BENTSUR RON Chairman & CEO 10% Owner |
210,000 | $0 | 3,225,459 (Direct) |
View |
| 2023-01-12 Option Award |
2023-01-13 5:04 pm |
N/A N/A |
Nuvectis Pharma Inc. | NVCT | Shemesh Shay Chief Dev. & Ops. Officer |
115,000 | $0 | 1,360,865 (Direct) |
View |